Page 2 - Guselkumab Provides Sustained Improvements In Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guselkumab provides sustained improvements in health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guselkumab Provides Sustained Improvements In Health Today - Breaking & Trending Today

Jennifer Soung, MD: Findings on Guselkumab for Psoriasis Among Patients with Diverse Skin Types

In this discussion, Soung discusses the VISIBLE study results on guselkumab and its design for individuals of diverse skin tones.
....

United States , Jennifer Soung , Southern California , Psoriasis Scalp Severity Index , Scalp Surface Area , Winter Clinical ,

Phase 3b Findings on Guselkumab Indicate Rapid Scalp Psoriasis Clearance in Patients of Color

These data were announced by Johnson & Johnson this week and show several encouraging findings regarding guselkumab’s use among patients of different skin types.
....

United States , Guselkumab Tremfya , Andrew Alexis , Weill Cornell Medicine , Maui Derm Hawaii , Guselkumab Significant , Rapid Scalp Clearance Data , Scalp Specific Investigator Global Assessment , Psoriasis Scalp Severity Index , Scalp Surface Area , Scalp Itch Numeric Rating Scale , Psoriasis Symptoms , Signs Diary , Dermatology Life Quality Index , People Of Color ,

Philip J. Mease, MD: New Assessment Tool for Psoriatic Arthritis Patients

In this discussion with Dr. Mease at ACR 2023, he covers findings on an assessment tool known as the PsA-5Ts for patients with psoriatic arthritis.
....

San Diego , United States , Philipj Mease , Swedish Medical Center , American College Of Rheumatology , University Of Washington School Medicine , Washington School , Psoriatic Arthritis ,

Philip J. Mease, MD: New Data on Guselkumab for Psoriatic Arthritis Patients

This interview segment with Dr. Mease featured a discussion about data presented at ACR 2023 on guselkumab and patients with psoriatic arthritis.
....

Spondyloarthritis Ps , Philipj Mease , University Of Washington School Medicine , Swedish Medical Center , American College Of Rheumatology , Drug Administration , Janssen Pharmaceuticals Inc , Corevitas Psoriatic Arthritis , Spondyloarthritis Registry , Janssen Pharmaceuticals , Washington School , Patient Reported Outcomes Through , Guselkumab Treatment , Patients With Active Psoriatic Arthritis , Real World Data From , Corevitas Psoriatic , Novel Psoriatic Arthritis , Thermometer Scale , Domains During Treatment , Pooled Analysis , Three Phase , Accessed November , Psoriatic Arthritis ,

Guselkumab for the Treatment of Crohn Disease, with Remo Panaccione, MD

In this interview, Remo Panaccione, MD, discusses results from the long-term extension of the GALAXI phase 2 study for guselkumab in Crohn disease and their implications in clinical practice. ....

Remo Panaccione , University Of Calgary , Drug Administration , Johnson Innovative Medicines , United European Gastroenterology Week , Inflammatory Bowel Disease Unit , Severely Active Crohn , Participants With Moderately , Demonstrates Long Term Benefit , Crohn Disease , Crohn X27s Disease , Inflammatory Bowel Disease , Phase 2 ,